Osiris Belaunzaran - Founder & Scientific Advisor

Professional Overview

Osiris Belaunzaran is an accomplished biotechnology entrepreneur and scientific leader with extensive expertise in immuno-oncology and autoimmunity. As the Founder of ImmunOs Therapeutics AG, he drives the strategic direction and scientific vision of the company, developing innovative therapies to harness the power of the immune system. Belaunzaran also serves as a Scientific Advisor at BackBone Ventures, providing his deep industry knowledge and technical insights to support the firm's investment portfolio.

Experience Summary

Current Roles

Founder, ImmunOs Therapeutics AG (2014 - Present)

Established ImmunOs Therapeutics AG and led the company's growth from inception to a leading player in the immuno-oncology space

Oversees all strategic and operational aspects of the company, including R&D, clinical development, and business development

Spearheads the development of novel immunotherapies that leverage the body's own defenses to fight cancer and autoimmune diseases

Scientific Advisor, BackBone Ventures (2022 - Present)

Provides strategic guidance and technical expertise to the venture capital firm's portfolio companies in the biotechnology and healthcare sectors

Advises on scientific and clinical development initiatives, identifying promising technologies and investment opportunities

Career Progression

Chief Scientific Officer, ImmunOs Therapeutics AG (2017 - 2021)

Directed the company's R&D efforts, leading the translation of innovative science into therapeutic candidates

Oversaw preclinical and clinical development programs, ensuring the timely advancement of the pipeline

Chief Executive Officer, ImmunOs Therapeutics AG (2014 - 2017)

Guided the company through its formative years, securing funding and establishing key strategic partnerships

Drove the growth of the organization, expanding the team and capabilities to support the development of the company's lead programs

Group Leader, UniversitätsSpital Zürich (2014 - 2017)

Led a research group focused on immuno-oncology and autoimmunity, driving advancements in the understanding of immune system regulation

Scientist, UniversitätsSpital Zürich (2012 - 2014)

Conducted cutting-edge research in the fields of antibody and protein therapeutics, autoimmunity, and immuno-oncology

Academic Background

Belaunzaran holds a Ph.D. in Neuroscience from the École polytechnique fédérale de Lausanne (EPFL), where he specialized in the development of antibody-based therapies and drug delivery systems. His postdoctoral work at the UniversitätsSpital Zürich further honed his expertise in autoimmunity and oncology, laying the foundation for his entrepreneurial and scientific leadership in the biotechnology industry.

Areas of Expertise

Immuno-oncology and autoimmunity

Antibody and protein therapeutic development

Translational research and clinical development

Biotechnology entrepreneurship and strategic leadership

Scientific advisory and venture capital investment

Professional Impact

Founding and leading ImmunOs Therapeutics AG, a successful biotechnology startup focused on innovative immunotherapies

Driving the development of novel therapeutic candidates that harness the immune system to fight cancer and autoimmune diseases

Serving as a trusted scientific advisor, providing strategic guidance and technical expertise to support the growth of biotechnology ventures

Contributing to the advancement of scientific knowledge and the translation of cutting-edge research into tangible therapies that improve patient outcomes

Conclusion

Osiris Belaunzaran is a visionary biotechnology leader who has dedicated his career to leveraging the power of the immune system to address some of the most pressing healthcare challenges. Through his entrepreneurial endeavors and scientific advisory roles, Belaunzaran continues to shape the future of the industry, driving innovation and translating groundbreaking research into life-changing therapies.